News|Articles|August 2, 2023
AI-Enabled Fetal Ultrasound Software Gets FDA Clearance
Author(s)Jeff Hall
With reported performance validation on over 17,000 ultrasound images, Sonio Detect employs artificial intelligence (AI) to help ensure quality criteria for fetal ultrasound imaging of the brain and heart.
Advertisement
The Food and Drug Administration (FDA) has granted 510(k) clearance for Sonio Detect (Sonio), a fetal ultrasound software as a service (SaaS) platform that utilizes artificial intelligence (AI) to enhance the assessment of fetal heart and brain structures.
Emphasizing Sonio Detect’s robust accuracy in identifying ultrasound views and quality criteria, Sonio said the technology demonstrated a 92 percent sensitivity in performance validation testing on over 17,000 ultrasound images.
Sonio claimed the technology with Sonio Detect increases the efficiency of fetal heart and brain assessment and may facilitate improved diagnosis of fetal anomalies.
“Bringing the first easy to use, manufacturer agnostic and efficient quality control solution to all OBGYNs, (maternal fetal medicine specialists) and sonographers, we believe better screening will lead to better detection of potential anomalies or reassurance to provide better maternal care. Our goal is to transform prenatal care by providing a reliable tool that ensures better health outcomes for both mothers and babies,” noted Cecile Brosset, the chief executive officer and co-founder of Sonio.
Advertisement
Related to this article
In the second of a three-part podcast episode, Wendie Berg, MD, PhD, FACR, FSBI, Manisha Bahl, MD, and Amy Patel, MD discuss how to handle disagreements with adjunctive AI in breast imaging, whether to include AI assessments in PACS, and whether patients should pay for the use of adjunctive AI.
Catch up on the top radiology content of the past week.
How will generative AI software be evaluated by the FDA in the future? What’s next for point-of-care ultrasound? What steps have been successful in facilitating adoption of AI applications across enterprise systems? Leaders in radiology and health care will be discussing these topics and more at the upcoming HLTH USA conference.
Catch up on the top radiology content of the past week.
Catch up on the most well-viewed video interviews from Diagnostic Imaging in September 2026.
In the third of a three-part podcast episode, Wendie Berg, MD, PhD, FACR, FSBI, Manisha Bahl, MD, and Amy Patel, MD discuss recent developments with autonomous AI in breast imaging and share their perspective on the overall potential of AI to help mitigate the radiologist shortage.
In a recent interview with Diagnostic Imaging, Joseph Cavallo, MD, MBA, offered insights on post-deployment monitoring with AI, the potential for improved workflow efficiency and the ongoing challenge of balancing essential clinical skills and AI literacy in the training of radiology residents and fellows.
The NEXT-Cue AI software, which incorporates analysis of brain MRI scans, reportedly facilitates prognostic assessments of potential progression from mild cognitive impairment (MCI) to Alzheimer’s disease within five years.
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
The Reading Room Podcast: A Closer Look at New Research on 177Lu-Edotreotide for Treating GEP-NETs
2
How AI, Theranostics and More Empowered Patients Have Led to Significant Changes in Radiology
3
FDA Clears MRI-Based AI Software for Prognostic Evaluation of Patients with Mild Cognitive Impairment
4
See the Real-World Impact of AI in Radiology
5